ES518975A0 - Un procedimiento para la preparacion de nuevos derivados de 2-piperazino primidina. - Google Patents

Un procedimiento para la preparacion de nuevos derivados de 2-piperazino primidina.

Info

Publication number
ES518975A0
ES518975A0 ES518975A ES518975A ES518975A0 ES 518975 A0 ES518975 A0 ES 518975A0 ES 518975 A ES518975 A ES 518975A ES 518975 A ES518975 A ES 518975A ES 518975 A0 ES518975 A0 ES 518975A0
Authority
ES
Spain
Prior art keywords
primidina
piperazino
procedure
preparation
new derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES518975A
Other languages
English (en)
Other versions
ES8400428A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmindustrie
Original Assignee
Pharmindustrie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmindustrie filed Critical Pharmindustrie
Publication of ES8400428A1 publication Critical patent/ES8400428A1/es
Publication of ES518975A0 publication Critical patent/ES518975A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/60—Three or more oxygen or sulfur atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Toxicology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ES518975A 1981-04-07 1983-01-13 Un procedimiento para la preparacion de nuevos derivados de 2-piperazino primidina. Granted ES518975A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8106924A FR2503162A1 (fr) 1981-04-07 1981-04-07 Nouveaux derives de piperazino-2 pyrimidine, procedes pour leur preparation et leur utilisation comme medicaments ou comme intermediaires pour la fabrication de medicaments

Publications (2)

Publication Number Publication Date
ES8400428A1 ES8400428A1 (es) 1983-10-16
ES518975A0 true ES518975A0 (es) 1983-10-16

Family

ID=9257094

Family Applications (4)

Application Number Title Priority Date Filing Date
ES511224A Granted ES511224A0 (es) 1981-04-07 1982-04-06 Un procedimiento para la preparacion de nuevos derivados de 2-piperazino pirimioina.
ES518974A Expired ES8400427A1 (es) 1981-04-07 1983-01-13 Un procedimiento para la preparacion de nuevos derivados de 2-piperazino pirimidina.
ES518976A Expired ES8400429A1 (es) 1981-04-07 1983-01-13 Un procedimiento para la preparacion de nuevos derivados de 2-piperazino pirimidina.
ES518975A Granted ES518975A0 (es) 1981-04-07 1983-01-13 Un procedimiento para la preparacion de nuevos derivados de 2-piperazino primidina.

Family Applications Before (3)

Application Number Title Priority Date Filing Date
ES511224A Granted ES511224A0 (es) 1981-04-07 1982-04-06 Un procedimiento para la preparacion de nuevos derivados de 2-piperazino pirimioina.
ES518974A Expired ES8400427A1 (es) 1981-04-07 1983-01-13 Un procedimiento para la preparacion de nuevos derivados de 2-piperazino pirimidina.
ES518976A Expired ES8400429A1 (es) 1981-04-07 1983-01-13 Un procedimiento para la preparacion de nuevos derivados de 2-piperazino pirimidina.

Country Status (21)

Country Link
US (1) US4535080A (es)
EP (1) EP0063509B1 (es)
JP (1) JPS57179167A (es)
AR (1) AR231442A1 (es)
AT (1) AT386199B (es)
AU (1) AU549748B2 (es)
CA (1) CA1175427A (es)
DE (1) DE3262374D1 (es)
DK (1) DK156722C (es)
ES (4) ES511224A0 (es)
FI (1) FI78909C (es)
FR (1) FR2503162A1 (es)
GR (1) GR77331B (es)
HU (1) HU187673B (es)
IE (1) IE52872B1 (es)
IL (1) IL65422A (es)
MA (1) MA19438A1 (es)
MX (1) MX156087A (es)
NO (1) NO158739C (es)
PT (1) PT74712B (es)
ZA (1) ZA822344B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3305524A1 (de) * 1983-02-18 1984-08-23 Celamerck Gmbh & Co Kg, 6507 Ingelheim Neue pyrimidinderivate
DE3321969A1 (de) * 1983-06-18 1984-12-20 Troponwerke GmbH & Co KG, 5000 Köln 2-pyrimidinyl-1-piperazin-derivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
JPS6143173A (ja) * 1984-08-06 1986-03-01 Mitsui Petrochem Ind Ltd 新規ピリミジン誘導体およびその製法
JP2561689B2 (ja) * 1986-02-24 1996-12-11 三井石油化学工業株式会社 神経疾患用治療薬
EP0799617A3 (en) * 1986-02-24 1997-11-12 Mitsui Petrochemical Industries, Ltd. Therapeutic agent for neurological diseases
WO1989000423A1 (en) 1987-07-09 1989-01-26 Pfizer Inc. 2-amino-5-hydroxy-4-pyrimidones
US4910204A (en) * 1988-06-28 1990-03-20 Pfizer Inc. 2-amino-5-hydroxy-4-pyrimidones
FI895821A7 (fi) * 1988-12-07 1990-06-08 The Wellcome Foundation Ltd Farmaseuttisesti aktivisia CNS-yhdisteitä
WO2007087279A2 (en) * 2006-01-23 2007-08-02 Board Of Trustees Of Michigan State University Methods for breeding glyphosate resistant plants and compositions thereof
CA2734486A1 (en) * 2008-08-20 2010-02-25 Southern Research Institute Substituted pyridine and pyrimidine derivatives and their use in treating viral infections
EP2432767B1 (en) * 2009-05-19 2013-06-26 Dow AgroSciences LLC Compounds and methods for controlling fungi
CN103204816B (zh) 2012-01-16 2016-04-27 中国人民解放军军事医学科学院毒物药物研究所 哌嗪基嘧啶类衍生物及其制备方法和用途

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL72956C (es) * 1947-11-12
FR2257294B1 (es) * 1973-07-06 1977-07-01 Ugine Kuhlmann
NL129219C (es) * 1965-12-16
US3980781A (en) * 1966-03-31 1976-09-14 Imperial Chemical Industries Limited Fungicidal composition and method containing 2-amino-pyrimidines
FR2173746B1 (es) * 1972-03-01 1975-04-25 Ugine Kuhlmann
FR2244520B1 (es) * 1973-07-06 1977-02-04 Ugine Kuhlmann
JPS578104B2 (es) * 1973-09-20 1982-02-15
GB1523274A (en) * 1974-08-05 1978-08-31 Ici Ltd Herbicidal compositions containing substituted pyrimidine
FR2281117A2 (fr) * 1974-08-09 1976-03-05 Ugine Kuhlmann Nouvelles piperazino-pyrimidines utilisables comme medicaments
US4166852A (en) * 1974-08-09 1979-09-04 Produits Chimiques Ugine Kuhlmann Piperazino-pyrimidines and their use as spasmolytic agents
FR2311776A1 (fr) * 1975-05-23 1976-12-17 Sogeras Diamino-2,4 bromo-5 chloro-6 pyrimidines et procede pour leur preparation
FR2417507A2 (fr) * 1977-07-28 1979-09-14 Ugine Kuhlmann Diamino-2,4 (ou -4,6) methylthio-5 pyrimidines herbicides

Also Published As

Publication number Publication date
NO158739C (no) 1988-10-26
FI821203A0 (fi) 1982-04-06
ES518976A0 (es) 1983-10-16
FI821203L (fi) 1982-10-08
ES8400428A1 (es) 1983-10-16
ES8306745A1 (es) 1983-06-01
IE52872B1 (en) 1988-03-30
ES518974A0 (es) 1983-10-16
NO158739B (no) 1988-07-18
NO821159L (no) 1982-10-08
ATA127682A (de) 1987-12-15
AR231442A1 (es) 1984-11-30
IE820774L (en) 1982-10-07
AU549748B2 (en) 1986-02-13
AU8245082A (en) 1982-10-14
DE3262374D1 (en) 1985-03-28
ZA822344B (en) 1983-02-23
DK156722C (da) 1990-02-19
MX156087A (es) 1988-07-04
IL65422A (en) 1985-04-30
FI78909B (fi) 1989-06-30
AT386199B (de) 1988-07-11
FR2503162A1 (fr) 1982-10-08
EP0063509B1 (fr) 1985-02-20
MA19438A1 (fr) 1982-12-31
CA1175427A (fr) 1984-10-02
FI78909C (fi) 1989-10-10
ES511224A0 (es) 1983-06-01
HU187673B (en) 1986-02-28
EP0063509A1 (fr) 1982-10-27
ES8400427A1 (es) 1983-10-16
DK156722B (da) 1989-09-25
IL65422A0 (en) 1982-07-30
GR77331B (es) 1984-09-11
DK154382A (da) 1982-10-08
PT74712A (fr) 1982-05-01
ES8400429A1 (es) 1983-10-16
FR2503162B1 (es) 1983-11-25
JPS57179167A (en) 1982-11-04
PT74712B (fr) 1983-10-25
US4535080A (en) 1985-08-13

Similar Documents

Publication Publication Date Title
ES518225A0 (es) Un procedimiento para la preparacion de nuevos derivados de oxabicicloalcano.
ES517542A0 (es) Un procedimiento para la preparacion de derivados de 3-hidroxi-ml-236-b.
ES513366A0 (es) Un procedimiento para la preparacion de nuevas n-aril-piperazin alcanamidas.
ES514264A0 (es) Un procedimiento para la preparacion de derivados de tiazolidi-nilalquilen-piperazinas.
ES517222A0 (es) Un procedimiento para la preparacion de derivados de acilmorrfinano.
ES512880A0 (es) Un procedimiento para la preparacion de derivados de 4-anilino-pirimidina.
ES516825A0 (es) Un procedimiento para la preparacion de nuevos derivados de 3-amino-pregn-5-eno.
ES509437A0 (es) Un procedimiento para la preparacion de derivados carbapenen-2-tio-sustituidos.
ES513880A0 (es) Un procedimiento para la preparacion de derivados de triazolurea.
ES510067A0 (es) Un procedimiento para la preparacion de nuevos derivados de benzoilurea.
ES521472A0 (es) Un procedimiento para la preparacion de un derivado de carbostirilo.
ES511224A0 (es) Un procedimiento para la preparacion de nuevos derivados de 2-piperazino pirimioina.
ES515655A0 (es) Un procedimiento para la preparacion de derivados de benzotiazolina.
ES513967A0 (es) Un procedimiento para la preparacion de derivados de etanola-mina.
ES510611A0 (es) Un procedimiento para la preparacion de derivados de desoxiuridina.
ES518288A0 (es) Un procedimiento para la preparacion de un derivado de piridoindol.
ES514263A0 (es) Un procedimiento para la preparacion de derivados de espiroti-azolidinil-piperazina.
ES514213A0 (es) Un procedimiento para la preparacion de nuevos derivados poliprenilicos.
ES508775A0 (es) Un procedimiento para la preparacion de derivados de ciclo- hepteno.
ES514596A0 (es) Un procedimiento para la preparacion de nuevos derivados de fosfolipidos.
ES517852A0 (es) Un procedimiento para la preparacion de derivados de bencenosulfonamidas.
ES514864A0 (es) Un procedimiento para la preparacion de derivados de trifluormetanosulfonanilida.
ES514486A0 (es) Un procedimiento para la preparacion de derivados de aminonaftaceno.
ES515365A0 (es) Un procedimiento para la preparacion de un derivado de furanocremona.
ES512463A0 (es) Un procedimiento para la preparacion de un derivado de beta-lactama.